Literature DB >> 6311746

Virus-specific antibody activity of different subclasses of immunoglobulins G and A in cytomegalovirus infections.

G A Linde, L Hammarström, M A Persson, C I Smith, V A Sundqvist, B Wahren.   

Abstract

Healthy donors and patients with primary or reactivated cytomegalovirus infections were examined for antiviral antibodies of the immunoglobulin G (IgG) and IgA subclasses. For this purpose, monoclonal antibodies against the four IgG and the two IgA subclasses were used in enzyme-linked immunosorbent assays with cytomegalovirus antigen. IgG1 and IgG3 were the principal anti-cytomegalovirus subclasses in serum samples from healthy donors and patients. IgG1 was higher in reactivated than in primary disease. Cytomegalovirus-specific IgG2 was detected only in serum samples with high total cytomegalovirus IgG. A few patients with high total serum IgG4 also had cytomegalovirus-specific IgG4 antibodies. During convalescence, there was no significant increase in total IgG of any subclass. Both IgA1 and IgA2 antibodies with cytomegalovirus specificity were detected in patients who had cytomegalovirus antibodies of the IgA class.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6311746      PMCID: PMC264549          DOI: 10.1128/iai.42.1.237-244.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  IgG1 subclass restriction of oligoclonal measles virus-specific IgG antibodies in patients with subacute sclerosing panencephalitis and in a patient with multiple sclerosis.

Authors:  B Vandvik; J B Natvig; E Norrby
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

Review 2.  Biological activities of immunoglobulins of different classes and subclasses.

Authors:  H L Spiegelberg
Journal:  Adv Immunol       Date:  1974       Impact factor: 3.543

3.  Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes.

Authors:  E Engvall; P Perlmann
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

4.  Coupling of enzymes to proteins with glutaraldehyde. Use of the conjugates for the detection of antigens and antibodies.

Authors:  S Avrameas
Journal:  Immunochemistry       Date:  1969-01

5.  Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens.

Authors:  G R Siber; P H Schur; A C Aisenberg; S A Weitzman; G Schiffman
Journal:  N Engl J Med       Date:  1980-07-24       Impact factor: 91.245

6.  Distribution of IgG subclasses in commercial and some experimental gamma-globulin preparations.

Authors:  F Skvaril; M Probst; R Audran; M Steinbuch
Journal:  Vox Sang       Date:  1977       Impact factor: 2.144

7.  Predominance of immunoglobulin G sub-class 3 among the complement-fixing antibodies to streptococcal M-associated protein.

Authors:  G E Mortimer; J P Widdowson
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

8.  Correlations between the concentrations of the four sub-classes of IgG and Gm Allotypes in normal human sera.

Authors:  A Morell; F Skvaril; A G Steinberg; E Van Loghem; W D Terry
Journal:  J Immunol       Date:  1972-01       Impact factor: 5.422

9.  Natural infection of man with group A streptococci. Levels; restriction in class, subclass, and type; and clonal appearance of polysaccharide-group-specific antibodies.

Authors:  W F Riesen; F Skvaril; D G Braun
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

10.  Studies on human antibodies. VI. Selective variations in subgroup composition and genetic markers.

Authors:  W J Yount; M M Dorner; H G Kunkel; E A Kabat
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

View more
  47 in total

1.  Estimation of IgG subclasses of anti-HCV (C100-3) in non-A, non-B fulminant, acute and chronic hepatitis and it's significance.

Authors:  S M Akbar; M Onji; Y Ohta
Journal:  Gastroenterol Jpn       Date:  1992-08

2.  Specificity of IgG subclass antibodies in different clinical manifestations of leprosy.

Authors:  S Dhandayuthapani; S Izumi; D Anandan; V N Bhatia
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

3.  Subclass restriction of human enterovirus antibodies.

Authors:  E G Torfason; C B Reimer; H L Keyserling
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

4.  Lymphocyte and IgG responses to different herpes simplex virus antigens in patients with frequent HSV-1 reactivations.

Authors:  P Ljungman; L Zetterqvist; V A Sundqvist; S Jeansson; A Heimdahl; B Wahren
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

5.  Monocyte and iscom enhancement of cell-mediated response to cytomegalovirus.

Authors:  B Wahren; S Nordlund; A Akesson; V A Sundqvist; B Morein
Journal:  Med Microbiol Immunol       Date:  1987       Impact factor: 3.402

6.  IgG subclass-specific antibodies to human cytomegalovirus (HCMV)-induced early antigens.

Authors:  A Hamann; H W Doerr
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

7.  Serum IgG subclasses and IgM imbalances in adult IgA mesangial glomerulonephritis and idiopathic Henoch-Schoenlein purpura.

Authors:  G Rostoker; M A Pech; S Del Prato; M Petit-Phar; A Ben Maadi; J M Dubert; P Lang; B Weil; G Lagrue
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

8.  Human immunoglobulin class and subclass specificity of Fc receptors induced by herpes simplex virus type 1.

Authors:  P J Johansson; T Hallberg; V A Oxelius; A Grubb; J Blomberg
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

9.  IgG subclass distribution of antibodies against S. aureus teichoic acid and alpha-toxin in normal and immunodeficient donors.

Authors:  L Hammarström; M Granström; V Oxelius; M A Persson; C I Smith
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

10.  Proportions of immunoglobulin isotypes in paralytic poliomyelitis and after vaccination.

Authors:  I Julkunen; P Ukkonen; M Stenvik; T Hovi; L Renkonen; O Mäkelä
Journal:  J Clin Immunol       Date:  1987-07       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.